Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of ECSP034578ApublicationCriticalpatent/ECSP034578A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Plural Heterocyclic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Los derivados de indolilmaleiida que comprenden un residuo de fenilo sustituido, naftilo, tetrahidronaftilo, quinazolinilo, quinolilo, isoquinolilo, o pirirnidinilo, tienen interesantes propiedades farmacéuticas, por ejemplo en el tratamiento y/o en la prevención de enfermedades o desórdenes inflamatorios agudos o crónicos mediados por células T, enfermedades auto inmunes, rechazo de injertos, o cáncer
ECSP0345782000-11-072003-05-07Derivados de indolilmaleimida como inhibidores de proteina de cinasa c
ECSP034578A
(es)